RASSF1 and neoplasm: Treatment with piR-8041 led to increased expression of tumor suppressor RASSF1, which encodes a tumor suppressor shown to mediate cell cycle arrest at the G1/S-phase transition via inhibition of cyclin D1 accumulation [44] and also shown to induce apoptotic cell death [45].